NeuroX1

Austin, United States

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

$220K raised

Mar 2024

Seed

Top Investors

TechstarsCapital FactoryDrive CapitalTrousdale VenturesNext Sequence

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeuroX1 raised?

NeuroX1 has raised $220K in total funding. The most recent round was Seed. The last funding was announced in March 2024.

Who are NeuroX1's investors?

NeuroX1's investors include Techstars, Capital Factory, Drive Capital, Trousdale Ventures, Next Sequence.

Where is NeuroX1 headquartered?

NeuroX1 is headquartered in Austin, United States.

What does NeuroX1 do?

Computational drug discovery leveraging generative AI to create therapeutics for neurodegenerative disorders.

What stage is NeuroX1 at?

NeuroX1 is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 11, 2024.

MLA

"NeuroX1 — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/neurox1. Accessed June 4, 2026.

APA

VCBacked. (2024). NeuroX1 — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/neurox1

Wikipedia (cite web)

{{cite web |title=NeuroX1 — Funding & Investors |url=https://www.vcbacked.co/company/neurox1 |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 11, 2024.